CAJ | 학술논문

目的：主要针对髋部骨折围手术期采用物理措施预防血栓形成的有效及安全性。方法整群选取于2013年7月-2014年8月该院收治就诊的192例符合手术条件的患者作为主要研究对象，并按照随机数字表法将其划分为甲组与乙组，两组患者各96例；其中甲组患者给予其应用物理措施预防血栓形成的方式加以治疗，而乙组患者则给予其应用低分子肝素钙预防血栓形成加以治疗；对两组患者的深静脉及肺栓塞发生率、出血性并发症发生率加以分析，观察比较两组患者的治疗措施效果。结果甲组96例患者采用物理措施预防血栓形成治疗方式的患者，其血栓形成发生率为8.33%，出血性并发症发生率为2.08%；而乙组96例患者采用低分子肝素钙血栓形成的患者血栓发生率为6.25%，其出血性并发症发生机率为4.17%。两组数据差异无统计学意义(P>0.05)。结论髋部骨折手术后单独采用物理措施来预防血栓形成的预防效果和单独采用低分子肝素预防血栓形成的预防效果相差无几。
목적：주요침대관부골절위수술기채용물리조시예방혈전형성적유효급안전성。방법정군선취우2013년7월-2014년8월해원수치취진적192례부합수술조건적환자작위주요연구대상，병안조수궤수자표법장기화분위갑조여을조，량조환자각96례；기중갑조환자급여기응용물리조시예방혈전형성적방식가이치료，이을조환자칙급여기응용저분자간소개예방혈전형성가이치료；대량조환자적심정맥급폐전새발생솔、출혈성병발증발생솔가이분석，관찰비교량조환자적치료조시효과。결과갑조96례환자채용물리조시예방혈전형성치료방식적환자，기혈전형성발생솔위8.33%，출혈성병발증발생솔위2.08%；이을조96례환자채용저분자간소개혈전형성적환자혈전발생솔위6.25%，기출혈성병발증발생궤솔위4.17%。량조수거차이무통계학의의(P>0.05)。결론관부골절수술후단독채용물리조시래예방혈전형성적예방효과화단독채용저분자간소예방혈전형성적예방효과상차무궤。
Objective To study the effectiveness and safety of physical measures in preventing thrombosis after hip fracture surgery. Methods 192 patients who were admitted to this hospital from July 2013 and August 2014 and met the operation condition were selected as the main research object and were divided into group A and group B according to the random number table method with 96 in each one. The patients in the group A were treated with physical measures to prevent the physical measures, while those in the group B were treated with low-molecular-weight heparin calcium to prevent the physical measures. The rate of deep venous thrombosis and pulmonary embolism, as well as the hemorrhagic complication rate of the patients in the two groups were analyzed, and the effect of the treatment was observed and compared. Results The incidence of thrombosis was 8.33% and hemorrhagic complication rate was 2.08% in the 96 patients of the group A, while those were 6.25% and 4.17% respectively in the group B, and no statistically significant difference can be found be-tween the two groups (P>0.05). Conclusion The effectiveness of physical measures is similar to that of low-molecular-weight heparin calcium in preventing thrombosis after hip fracture surgery.